Basic patterns and information from different regions
Our sets of data include cities of Hubei province, other regions in China, and 53 states and territories in the USA. The first set of data was obtained from 17 cities in the Hubei Province (Supplemental Table 1). These 17 cities had a total of 68,128 patients diagnosed with COVID-19 and 4512 deaths from COVID-19. The total population in these 17 cities is 59.965 million, living in an area of 162,245 km2. The calculated average COVID-19 mortality rate is 0.665%0. The second set of data is the population density and the total number of people in other provinces and cities or other regions in China (Supplemental Table 2). The collected data show that the average population density of these cities and provinces is 1106 km2. However, the morbidity rate in these places is very low, and the prevalence rate is 0.025 per thousand. The third set of data is the population density and prevalence of 53 major cities in states and territories in the USA (Supplemental Table 3). The population density of these cities is averaged to be 90 per square kilometer. The morbidity is 1.412 per thousand people.
Association between population density and mortality in Hubei province
Our data indicate that population density of the 17 cities in the Hubei province is positively associated with the disease mortality. There are considerable differences in the population density and death rate among these 17 cities. Although on average, the population density is 489 persons per square kilometers, the difference from city to city is large, ranging from 24.6 in Shennongjia to 1461 in Enshi (Fig. 1a). Similarly, on average, the average disease morbidity is rate is 3.49% ranging from 0.025 to 4.167% (Fig. 1b). Correlation analysis indicated that there is a positive association between the population density and disease morbidity, with an r value of 0.620 (Fig. 1c).
Association between population density and morbidity in major cities in the US states and territories. Our data indicate that population density in the US states and territories is positively associated with disease morbidity. The population density of the US states and territories is much lower than that of China; nevertheless, there are also considerable differences in the density and death rate among different locations in the US states and territories. On average, the US population density is 80 persons per square kilometer; the difference from state to state is from as low as 0.49 in Alaska to as high as 438.00 in New Jersey (Fig. 2a). Similarly, on average, the disease morbidity has a rate of 1.41%, with a variation from 0.07% in South Carolina to 9.94% in New York (Fig. 2b). Further comparison indicates that there is a positive correlation between the population density and disease morbidity, with an r value of 0.552 (Fig. 2c). There is apparently a highly consistent relationship between population density and COVID-19 mortality.
Because the date of the first cases reported in different cities in the USA is considerably different, and the disease epidemic is still ongoing, we analyzed the relation between the date of the first case and the morbidity to determine whether the date of the first case influenced the rate of morbidity (Supplemental Table 4). Surprisingly, there was no association between them, with an r value of − 0.1288.
Non-association between population density and mortality among other regions in China
Since the disease in other regions of China was well under control, an epidemic did not materialize into the general population before the elimination of the infection source. We hypothesized that in this case, the population density in other regions would not be associated with the disease morbidity. These regions include 33 regions, with an average of 1106 persons per kilometer but with large differences from 2.80 persons per kilometer in XiZang to 13,984 persons per kilometer in Aomen (Fig. 3a). The disease morbidity rate is low, all below 0.1%, except Shandong which had a rate of 0.4% (Fig. 3b). The r value for the correlation between population density and disease morbidity rate is 0.04 (Fig. 3c). Thus, the data from other regions in China serve as a negative control; when the COVID-19 disease does not morph into an epidemic, population density is not associated with the disease morbidity.
Difference between China and the USA on the measures of social distance and the impact of disease epidemic
By analyses of the data from the Hubei province in China and 53 major US cities in the US states and territories, we obtained the positive correlations between the population density and the disease morbidity. We next asked whether there is a difference between these two data sets of cities on the impact of the disease epidemic. We calculated the morbidity of population density from 100 from 1000 using the linear formula obtained from the Hubei and major cities of the US states and territories. Although both data sets have positive correlation between the population density and morbidity, they are not at the same degree (Table 1). Based on the formula derived from Hubei province, the morbidity increased from 0.177 to 1.377 when the population density increased from the 100 to the 1000 (Fig. 4a). On the other hand, in major cities and territories of the USA, the morbidities increased from 1.453 to 7.93 when the population density increased from the 100 to the 1000 (Fig. 4b). The increases in rates between these two sets of data are significantly different (Fig. 4c).
Table 1 Predicated morbidity at different population density in the USA and Hubei, China